Orthofix International (OFIX) Misses Q2 EPS by 51c, provides guidance
Tweet
Share
E-mailGet Alerts OFIX Hot Sheet
Price: $9.15 -1.51%
EPS Growth %: +52.6%
Financial Fact:
Operating income (loss): 9.27M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +52.6%
Financial Fact:
Operating income (loss): 9.27M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Orthofix International (NASDAQ: OFIX) reported Q2 EPS of ($0.88), $0.51 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $198.6 million versus the consensus estimate of $195.22 million.
GUIDANCE:
Orthofix International sees FY2024 revenue of $795-800 million, versus the consensus of $793.8 million.
For earnings history and earnings-related data on Orthofix International (OFIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Google and Blackstone data-center venture hits delays at key sites - Bloomberg
- BMO Capital Starts Abercrombie & Fitch (anf) at Outperform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
